This study outlines the molecular DNA findings derived from 12 separate pre
natal diagnoses offered to families with a history of facioscapulohumeral m
uscular dystrophy. A high risk of the fetus being affected was identified i
n five pregnancies. Several practical problems are discussed, particularly
those arising from the quality and quantity of DNA made available for molec
ular diagnosis. Evidence of the 4q35 and 10q26 telomeric exchanges is prese
nt in 20 per cent of the general population and the specificity of the test
is 95 per cent. The eventual isolation and functional characterization of
the FSHD gene should allow us to unravel many of the complexities currently
associated with the molecular diagnosis of this disorder. Copyright (C) 19
99 John Wiley & Sons, Ltd.